Tazonis (Piperacillin + Tazobactam 4.5 g / 1.125g Injection)

Overview:

TAZONIS Injection contains Piperacillin and Tazobactam. The combination distributes rapidly after parenteral administration and penetrates well into skin, lung, and intestinal mucosa. Compared with other beta-lactam-beta-lactamase inhibitor combinations, Piperacillin-Tazobactam has comparable efficacy in the treatment of intraabdominal infections, skin and soft tissue infections, and upper and lower respiratory tract infections.

 

 

 

 


Piperacillin is a broad-spectrum β-lactam antibiotic of the ureidopenicillin class.
Tazobactam is a beta-lactamase inhibitor.

TAZONIS Injections can be used in the treatment of the following conditions:

  • Nosocomial and community acquired pneumonia
  • Intra-abdominal infections
  • Skin and soft tissue infections
  • Female pelvic infections


Infuse one TAZONIS Injection over 30 minutes every 6 hrs for 7–14 days, or as directed by Physician.

Piperacillin exerts bactericidal activity by inhibiting septum formation and cell-wall synthesis of susceptible bacteria. Tazobactam broadens the spectrum of Piperacillin by making it effective against organisms that express beta-lactamase.